Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myotubularin related protein 14 pseudogene is a non-coding genomic sequence homologous to the MTMR14 gene, which encodes a member of the myotubularin phosphatase family. Pseudogenes like LOC100131011 are typically non-functional and do not produce active proteins. While the protein-coding MTMR14 gene is associated with diseases such as centronuclear myopathy due to its role in phosphoinositide dephosphorylation, the pseudogene itself does not have direct biological functions, therapeutic relevance, or drug interactions[3][5][6]. Its presence in the genome is largely used for reference in genomic studies and does not translate to clinical significance. For structured information and clinical/functional relevance, the protein-coding gene Myotubularin related protein 14 (MTMR14) should be referenced instead of its pseudogene[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myotubularin related protein 14 pseudogene.